These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1666684)

  • 1. High-dose naloxone modifies cardiovascular and neuroendocrine function in ambulant subjects.
    McMurray RG; Newbould E; Bouloux P; Besser GM; Grossman A
    Psychoneuroendocrinology; 1991; 16(5):447-55. PubMed ID: 1666684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.
    Barbarino A; De Marinis L; Tofani A; Della Casa S; D'Amico C; Mancini A; Corsello SM; Sciuto R; Barini A
    J Clin Endocrinol Metab; 1989 Mar; 68(3):523-8. PubMed ID: 2493035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal twenty-four hour pattern of pulsatile luteinizing hormone secretion and the response to naloxone in women with hyperprolactinaemic amenorrhoea.
    Tay CC; Glasier AF; Illingworth PJ; Baird DT
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):599-606. PubMed ID: 8252751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of baclofen on LH and cortisol responses to naloxone in normal men.
    Coiro V; Volpi R; Marcato A; Bertoni P; Cavazzini U; Caffarri G; Capretti L; Rossi G; Chiodera P
    Psychoneuroendocrinology; 1992 Nov; 17(6):667-71. PubMed ID: 1337607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of luteinizing hormone and follicle-stimulating hormone in circulation by interactions between endogenous opioids and oestradiol during the peripubertal period of heifers.
    Wolfe MW; Roberson MS; Stumpf TT; Kittok RJ; Kinder JE
    J Reprod Fertil; 1992 Sep; 96(1):165-74. PubMed ID: 1432947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of epinephrine in the cardiovascular effect of naloxone in humans.
    Hernandez J; Pérez-Ojeda E; Serrano JS; Castillo JR; Serrano MI
    Clin Ther; 1985; 7(4):418-23. PubMed ID: 4016825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal effects of high dose naloxone in humans.
    Cohen MR; Cohen RM; Pickar D; Kreger D; McLellan C; Murphy DL
    Neuropeptides; 1985 Jul; 6(4):373-80. PubMed ID: 3930990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis.
    Lanfranco F; Bonelli L; Baldi M; Me E; Broglio F; Ghigo E
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3633-9. PubMed ID: 18559917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol effects on naloxone-stimulated luteinizing hormone, follicle-stimulating hormone and prolactin plasma levels in female rhesus monkeys.
    Mello NK; Mendelson JH; Bree MP; Skupny A
    J Pharmacol Exp Ther; 1988 Jun; 245(3):895-904. PubMed ID: 3133465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteinizing hormone and cortisol responses to naloxone in normal weight women with bulimia.
    Coiro V; d'Amato L; Marchesi C; Capretti L; Volpi R; Roberti G; Cerri L; Chiodera P
    Psychoneuroendocrinology; 1990; 15(5-6):463-70. PubMed ID: 2101966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
    Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
    J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of aging on the opioid mechanisms controlling gonadotropin and cortisol secretion in man.
    Coiro V; Passeri M; Volpi R; Marchesi M; Bertoni P; Fagnoni F; Schianchi L; Bianconi L; Marcato A; Chiodera P
    Horm Res; 1989; 32(4):119-23. PubMed ID: 2560454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of naloxone on diurnal rhythms in mood and endocrine function: a dose-response study in man.
    Martin del Campo AF; Dowson JH; Herbert J; Paykel ES
    Psychopharmacology (Berl); 1994 May; 114(4):583-90. PubMed ID: 7855219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women.
    Bondanelli M; Ambrosio MR; Franceschetti P; Guerrini R; Valentini A; degli Uberti EC
    Hum Reprod; 1998 May; 13(5):1159-62. PubMed ID: 9647539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of naloxone and an enkephalin analog on serum prolactin, cortisol, and gonadotropins in the chimpanzee.
    Gosselin RE; Blankstein J; Dent DW; Hobson WC; Fuller GB; Reyes FI; Winter JS; Faiman C
    Endocrinology; 1983 Jun; 112(6):2168-73. PubMed ID: 6406210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate.
    Gindoff PR; Ferin M
    Endocrinology; 1987 Sep; 121(3):837-42. PubMed ID: 3113919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease.
    Cagnacci A; Melis GB; Soldani R; Bonuccelli U; Piccini P; Napolitano A; Muratorio A; Fioretti P
    Neuroendocrinology; 1991 Jun; 53(6):549-55. PubMed ID: 1678880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
    Rossmanith WG; Mortola JF; Yen SS
    J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.